D
37
2
CVS
32
3
CFG
44
4
AAPL
65
-2
FMC
20
-2
MNST
59
7
GOOG
81
-2
VIX
15
7
BIIB
42
2
ADT
32
4
MS
72
2
ECL
54
-3
KHC
13
-2
GILD
58
2
NEE
42
-2
PEP
33
-3
PVH
59
-3
KIM
58
-2
GT
49
2
VFC
58
2
D
37
2
CVS
32
3
CFG
44
4
AAPL
65
-2
FMC
20
-2
MNST
59
7
GOOG
81
-2
VIX
15
7
BIIB
42
2
ADT
32
4
MS
72
2
ECL
54
-3
KHC
13
-2
GILD
58
2
NEE
42
-2
PEP
33
-3
PVH
59
-3
KIM
58
-2
GT
49
2
VFC
58
2
Financhill
Back

Financial Select Sector SPDR Fund Vs. Aligos Therapeutics Industry Stock Comparison

Buy
62

XLF
Financial Select Sector SPDR Fund

Last Price:
$48.75
Seasonality Move:
-0.05%
Buy
65

ALGS
Aligos Therapeutics

Last Price:
$41.28
Seasonality Move:
-16.03%
Buy
62
Financial Select Sector SPDR Fund (XLF) is a Buy

Is Financial Select Sector SPDR Fund a Buy, Sell or Hold?

  • The current Financial Select Sector SPDR Fund [XLF] share price is $49.11. The Score for XLF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • XLF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

XLF Stock Price Chart

What is Financial Select Sector SPDR Fund's stock price today?

  • The Financial Select Sector SPDR Fund share price today is $49.11
    The current trend is moderately bearish and XLF is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

XLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 49.26 Sell
Chaikin Money Flow: 18673136 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.88 - 50.82) Sell
Bollinger Bands (100): (44.1 - 49.3) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.71 Buy
Relative Strength Index (14 RSI): 81.52 Buy
Chaikin Money Flow: 630913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.74 - 36.8) Buy
Bollinger Bands (100): (6.83 - 25.23) Buy

XLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 49.75 Sell
50-day SMA: 48.9 Buy
200-day SMA: 44.12 Buy
8-day EMA: 48.9 Buy
20-day EMA: 49.26 Sell
50-day EMA: 48.64 Buy
200-day EMA: 44.54 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.61 Buy
20-day SMA: 32.22 Buy
50-day SMA: 20.6 Buy
200-day SMA: 16.51 Buy
8-day EMA: 38.12 Buy
20-day EMA: 32.66 Buy
50-day EMA: 24.43 Buy
200-day EMA: 18.11 Buy

Financial Select Sector SPDR Fund Earnings Growth & XLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Financial Select Sector SPDR Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):